Untitled UI logotext
Home

Features

Use cases

Knowledge bases
Stakeholder mapping
Clinical and scientific landscaping
Competitive and digital landscaping
Self-serve analytics
Easily explore data visualizations and structured insights across multiple sources.
Read more
Integrated insights feed
Collaborate in real time by commenting, discussing, and refining intelligence directly within the platform.
Read more
Custom alerts
Set personalized alerts for new intelligence that impacts your strategy.
Read more
AI-enhancements
AI-powered summarization and conversational AI distill dense publications into clear takeaways.
Read more
HelixAI
Analyze your landscape in seconds with an AI-enhanced knowledge management platform built around your unique situation.
Explore HelixAI
Watch demo
Medical Affairs
Stay ahead of the scientific conversation and build stronger engagement strategies.
Read more
Market Access
Deliver confident, evidence-backed decisions in dynamic and budget-constrained environments.
Read more
Clinical Development
Compare competitor activity, synthesize key publications, and identify the smartest sites and endpoints.
Read more
Cross-functional teams
Every insight is linked, every decision is grounded, and every update builds on what’s already known.
Read more
HelixAI use cases
Analyze your landscape in seconds with an AI-enhanced knowledge management platform built around your unique situation.
Use cases
Watch demo

Stakeholder mapping

Key Opinion Leaders (KOLs)
Optimize your stakeholder engagement strategy.
Digital Opinion Leaders (DOLs)
Learn how DOLs are emerging as powerful voices.
Rising Stars
Discover the KOLs of tomorrow, today.
Research center analysis
New
Enhance your stakeholder engagement strategy.

.

Payer Influencing Key Opinion Leaders (PIKOLs)
Increase your likelihood of launch success with PIKOLs.
Key Clinical Investigators (KCIs)
Elevate your clinical trial strategy through KCIs.
Trial site analysis
Adopt a data-driven approach to site selection.

Clinical  landscaping

Epidemiology
Lead a more targeted approach.
Burden of disease and unmet needs
Drive informed decision-making.

Scientific landscaping

Bibliometric analysis
Reveal emerging research, trends, and collaborators.
Journal scoping
Maximize the impact of your publication strategy.

Competitive lanscaping

Development pipelines
Inform drug and trial design, and comparative effectiveness.
Marketed products, regulatory approvals, and HTA decisions
Understand regulatory approval processes.
Market value and price benchmarking
Minimize risk and promote informed decision-making.

Digital landscaping

Digital signals
Track the online conversation shaping your brand, competitors, and therapy area.
Narrative and topic analysis
Close the gap between what you say and what your stakeholders actually hear.
Patient voice
Uncover real-world unmet needs, symptom narratives, and treatment perceptions.
Solutions

Solutions

Success stories
Early-stage strategy & opportunity mapping
Evidence development & decision support
Enablement & execution at scale
Explore our solutions
We work with pharma, biotech, and consumer health teams to solve complex data challenges with clarity and speed.
Read more
Meet the consulting team
Our people bring together years of experience in healthcare, data science, and enterprise software.
Read more
How we work
Our process is built to uncover what matters, act on it quickly, and leave you with lasting tools that keep delivering.
Read more
Why we're different
We combine a unique data science delivery platform, a rich data landscape, and proven software delivery.
Read more
Flexible solutions,
grounded in expertise
We work with pharma, biotech, and consumer health teams to solve complex data challenges with clarity and speed.
Solutions builder
Contact

Early-stage strategy & opportunity mapping

Cutting through the noise after FDA approval
Revealing true reactions and influential voices online
Elevating a competitive strategy in a new therapy area
Helping new teams ramp up and compete
Enhancing strategic decision-making: An acquisition case study
Evaluating opportunity, resources, and long-term fit
Exploring new market potential for an established supplement
Identifying new indications and engagement opportunities
Mapping scientific potential to support OTC market expansion
Revealing new opportunities through science and strategy
Positioning an early-stage asset for real-world success
Defining opportunity and story to secure funding
Strategic clarity for Phase 3 and beyond
Shaping smarter trials and future positioning
Strategic impact through smarter conference engagement
Strategic impact through smarter conference engagement

Evidence Development & Decision Support

Assessing product risk through real-world digital evidence
Unbiased digital insights to guide global decisions extra wording
Bridging data gaps to make better launch decisions
Clarifying indication strategy through connected insight for better decisions
Creating an intelligence hub to guide early scientific decisions
Unifying research data to guide R&D strategy
Designing a trial with the finish line in mind
Shaping strategy to achieve standard of care
Shaping medical content strategy with digital intelligence
Decoding HCP needs to shape better content

Enablement & execution at scale

Optimising trial performance through live data and expert insight
Improving recruitment and redesigning trial operations
Turning MSL feedback into strategic advantage
Structuring MSL insights to shape launch strategy
Tech & data
Explore our tech and data
Our expert teams use proprietary tech and a rich data landscape to build lasting solutions that work in the real world.
Read more
Introducing HelixAI
Built to make navigating, sharing, and acting on project outputs effortless
Read more
Our data landscape
We enhance every project with trusted, high-resolution datasets so you can move faster with greater confidence.
Read more
Building scalable software
Confidently scale from testable prototypes to full enterprise systems, all grounded in real-world delivery.
Read more
Flexible solutions,
grounded in expertise
We work with pharma, biotech, and consumer health teams to solve complex data challenges with clarity and speed.
Solutions builder
Contact
Medical Affairs
Stay ahead of the scientific conversation and build stronger engagement strategies.
Read more
Clinical Development
Compare competitor activity, synthesize key publications, and identify the smartest sites and endpoints.
Read more
Cross-functional teams
Every insight is linked, every decision is grounded, and every update builds on what’s already known.
Read more
Use cases
Analyze your landscape in seconds with an AI-enhanced knowledge management platform built around your unique situation.
Use cases
Watch demo

Early-stage strategy & opportunity mapping

Assessing product risk through real-world digital evidence
Unbiased digital insights to guide global decisions extra wording
Bridging data gaps to make better launch decisions
Clarifying indication strategy through connected insight for better decisions
Creating an intelligence hub to guide early scientific decisions
Unifying research data to guide R&D strategy
Designing a trial with the finish line in mind
Shaping strategy to achieve standard of care
Shaping medical content strategy with digital intelligence
Decoding HCP needs to shape better content

Evidence Development & Decision Support

Cutting through the noise after FDA approval
Revealing true reactions and influential voices online
Elevating a competitive strategy in a new therapy area
Helping new teams ramp up and compete
Enhancing strategic decision-making: An acquisition case study
Evaluating opportunity, resources, and long-term fit
Exploring new market potential for an established supplement
Identifying new indications and engagement opportunities
Mapping scientific potential to support OTC market expansion
Revealing new opportunities through science and strategy
Positioning an early-stage asset for real-world success
Defining opportunity and story to secure funding
Strategic clarity for Phase 3 and beyond
Shaping smarter trials and future positioning
Strategic impact through smarter conference engagement
Strategic impact through smarter conference engagement

Competitive lanscaping

Optimising trial performance through live data and expert insight
Improving recruitment and redesigning trial operations
Turning MSL feedback into strategic advantage
Structuring MSL insights to shape launch strategy
HelixAIConsultingAboutSolutionsResourcesGlossary
Resources

Resources

Case studies
Learn how we have helped our clients to make impactful changes.
Our stories
Read about the day-to-day lives of VISFO's team members.
Press releases
Hot off the press! Our latest news features and events.

.

Insights
Explore the latest insights and knowledge from the field.
Partnerships
Updated
See who we have joined together with to deliver excellence.
Glossary
Resource of commonly used terms within the sector.

Featured insights

Designing better advisory boards: The power of data-driven KOL selection
Read more
Why better asset evaluation needs to begin earlier than you think
Read more
Read all insights
Resources area
Get in touch
HomeSolutionsTechnology & dataAboutResourcesResourcesGlossary
Resources

Resources

Case studies
Learn how we have helped our clients to make impactful changes.
Our stories
Read about the day-to-day lives of VISFO's team members.
Press releases
Hot off the press! Our latest news features and events.

.

Insights
Explore the latest insights and knowledge from the field.
Partnerships
Updated
See who we have joined together with to deliver excellence.
Glossary
Resource of commonly used terms within the sector.

Featured insights

Designing better advisory boards: The power of data-driven KOL selection
Read more
Why better asset evaluation needs to begin earlier than you think
Read more
Read all insights
Resources area
Get in touch
Contact

Modern Slavery
Act Statement

Updated June 2023

Modern Slavery Act Statement

Modern slavery is a crime and a violation of fundamental human rights. It takes various forms, such as slavery, servitude, forced and compulsory labor and human trafficking, all of which have in common the deprivation of a person's liberty by another in order to exploit them for personal or commercial gain.

We have a zero-tolerance approach to modern slavery and we are committed to acting ethically and with integrity in all our business dealings and relationships and to implement and enforce effective systems and controls to ensure modern slavery is not taking place anywhere in our own business or our supply chain.

We are also committed to ensuring there is transparency in our own business and in our approach to tackling modern slavery throughout our supply chain. We expect the same high standards from all of our contractors, suppliers and other business partners. As part of our contracting processes, we include specific prohibitions against the use of forced, compulsory or trafficked labor, or anyone held in slavery or servitude and we expect that our suppliers will hold their own suppliers to the same high standards.

This policy applies to all persons working for us or on our behalf in any capacity, including employees at all levels - directors, officers, external consultants, third-party representatives and business partners.

This policy does not form part of any employee’s contract of employment and may be amended at any time as appropriate.

1. Responsibility

The CEO has the overall responsibility for ensuring this policy complies with our legal and ethical obligations, and that all those under our control comply with it, implementing this policy, monitoring its use and effectiveness, dealing with any queries about it, and ensuring procedures are effective in countering modern slavery.

2. Compliance with the policy

The company expects that its officers, employees, associates, contractors and stakeholders in general are aware and comply with this policy.

The prevention, detection and reporting of modern slavery in any part of our business is the responsibility of all those working for us or under our control. As such, people are required to avoid any activity that might lead to, or suggest, a breach of this policy.

The CEO must be notified as soon as possible if anyone involved with the company believes or suspects that a conflict with this policy has occurred, or may occur in the future.

Everyone is encouraged to raise concerns about any issue of suspicion of modern slavery in any parts of our business at the earliest possible stage.

We aim to encourage openness and will support anyone who raises genuine concerns in good faith under this policy, even if they turn out to be mistaken. We are committed to ensuring no one suffers any detrimental treatment as a result of reporting in good faith their suspicion that modern slavery of whatever form is or may be taking place in any part of our own business.

‍

This policy has been approved & authorized by:  

Name: Dr Max Noble Position: Chief Executive Officer Last Review: June 2023

‍

Untitled UI logotextLogo
Making science personal.
X logo iconLinkedIn logo icon
Home
Solutions
Tech & Data
About us
Contact
Resources
Case studies
Insights
Our stories
Partnerships
Press releases
Glossary
© 2025 VISFO. All rights reserved
TermsPrivacy CookiesMSAS